05.21.14 -- Merck Assesses Single Use: Does It Make Sense At A Large Scale?
This Webinar from World Courier will discuss increasingly complex pharmaceutical products, and expanding, more rigid regulatory requirements that are continuing to demand increased awareness from bio-pharmaceutical companies worldwide. With quality, safety and compliance issues challenging the efficiency of pharmaceutical supply chains, we have invited three industry experts to share their knowledge and experience in how to successfully navigate and manage this ever changing environment. Learn more.
From The Editor: Merck Assesses Single Use: Does It Make Sense At A Large Scale? By Trisha Gladd, Editor, Pharmaceutical Online and Bioresearch Online
In an industry as conservative as the pharmaceutical industry, it is common practice to be adverse to new technologies because they are often viewed as too much of a risk. However, in this effort to play it safe, companies force themselves into a repetitive state of employing technologies that may not be the most efficient or effective. Rather than getting stuck in old habits — or conversely, jumping too quickly into new ones — Merck has put together a group of teams it calls the Technology Encouragement Collaborators, or TEC, to look at new technologies and determine whether or not to implement them.
Article: Inflammation And The New Drug Development Paradigm By Thomas Vihtelic, DVM, Ph.D., MPI Research
Opportunities abound for new treatments for inflammatory diseases, which afflict millions of people. Upward spiraling development costs, however, impede progress and delay relief for patients suffering from such debilitating diseases.
Article: The Art Of Optimizing Small Biotech Market Caps — From Scientific Dreams To Strategic Reality Moderated and edited by Wayne Koberstein, Executive Editor
Last month, in Part One of this discussion, our panel of company executives and investment experts examined the key factors that can determine a small life sciences company’s valuation and market cap. As the sun rose outside the large meeting room window overlooking the San Francisco skyline, our roundtable — held during the confluence of industry events surrounding the JP Morgan Healthcare Conference in January 2014 — continued to explore the effects of valuation and market cap on such a company and what it can do to optimize its value at every stage of its development.
White Paper: Quantitative Determination Of Bisphosphonate Pharmaceuticals And Excipients By Capillary IC-MS By Leo Jinyuan Wang and William C. Schnute, Thermo Fisher Scientific
Bisphosphonates are a group of compounds that are used as active pharmaceutical ingredients (APIs) to treat bone disorders including osteoporosis, Paget’s disease, and hypercalcemia. Typical methods for bisphosphonates analysis include liquid chromatography (LC) with derivatization and/or ion pairing, ion chromatography (IC), capillary electrophoresis (CE), and gas chromatography (GC) with derivatization.
Application Note: Optimization Of Monoclonal Antibody Production Employing Noninvasive Sensor Technology By Sartorius Stedim Biotech
Large-scale, high-density fermentation and high-yield production of monoclonal antibodies are major aims of process development in the biopharmaceutical industry. On the other hand, there is an increasing demand for highly flexible and scalable production processes adapted to lab-scale, single-use culture vessels, i.e., to generate sufficient material for R&D or for preclinical applications.
Gain the insight and contacts you need to make your single-use platforms more efficient, economical, and meet more complex drug demands at IBC's 11th Single-Use Applications for Biopharmaceutical Manufacturing conference, taking place June 9 and 10, 2014, in Boston, MA.
Bioresearch Online readers can save 20 percent off the standard rate with priority code B14187BIO20 during online registration at http://bit.ly/1jHaZ86.
MPC/MPX Back-to-Back Body and Insert Adapters from CPC give end users the flexibility of connecting off-the-shelf, single-use systems that feature identical coupling connections at the end of their tubing. CPC is the leader in the design and manufacture of single-use connection technology and connectors for the life sciences market, offering a wide variety of bioprocessing solutions including sterile connect, sterile disconnect, SIP connections, and quick connects.
The imPULSE MDS platform has all the benefits and mixing capabilities of the imPULSE stationary platform except that the motor is mounted on the docking station allowing tanks to be easily interchanged. A loading/unloading hoist will ease the transfer of the shipping containers on and off the station.
Following the discussion on monoclonal antibody (MAb) processing, partly conflicting observations can be made: Some push costs in the foreground of process technology discussion, while others emphasize robustness and peace of mind (low risk).